Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1281-1300 of 1,550 trials

Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?

NCT00583648

The implementation of nursing urinanlysis protocols based off of symptoms of urinary infections will significantly decrease the length of a patient's stay in the Emergency Department.

Urinary Tract Infections

University of California, Los AngelesStarted Feb 2008

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

NCT02283320

BIND-014 (docetaxel nanoparticles for injectable suspension) is being studied in patients with v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation positive or squamous cell non-small cell lung cancer (NSCLC) who have progressed after treatment of one prior platinum-containing chemotherapy regimen.

KRAS Positive Patients With Non-small Cell Lung CancerSquamous Cell Non-small Cell Lung Cancer

BIND Therapeutics69 participantsStarted Sep 2014

Chandler, Arizona, United States • Goodyear, Arizona, United States • Phoenix, Arizona, United States +29 more locations

Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Rheumatoid Arthritis Trials in Other Cities

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Intradiscal rhGDF-5 Phase I/II Clinical Trial

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Study of Tumor Samples From Patients With Ewing Sarcoma

Blood and Marrow Transplant Clinical Research Network

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

GORE Flow Reversal System and GORE Embolic Filter Extension Study

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Other Conditions in Los Angeles